Biotrisse Classic Detail 15
Description
A classic preparation with cross-linked hyaluronic acid for detailed correction of fine, superficial wrinkles and folds; strengthening and firming skin. Reticulated hyaluronic acid-based gel for intradermal implantation.
Contains: 1 disposable sterile syringe containing 1 ml of reticulated Hyaluronic Acid-based gel (15 mg / ml), 2 sterile disposable needles 30G 1/2″ (CE 0123).
Important: the dermal injection treatment must be performed by an authorized practitioner in accordance with country regulations.
Technical features
| Concentration | 15 mg / ml |
| Reticulation level | medium |
| Volumization level | 2 |
| Correction areas | Perioral wrinkles Nasolacrimal furrows Crow’s feet Neck Décolletage |
| Indications | Correction of surface wrinkles and small expression lines Contour filling with a biorevitalizer effect |
| Injection depth | Surface and mid-level dermis |
| Injection methods | Thin channel Linear retrograde Layer-by-layer in combination with other Biotrisse preparations Radial |
| Effective for | 6–8 months |
| Session schedule | A repeat procedure for contour plasticity is recommended in 6 months |
| Package | 1 × 1 ml in sterile blister |
| Needle | 2 × 30G 1/2 |
| Post-procedure set for correction zones | 1 × 5 ml Biotrisse CHA Cream (Post-filler cream) 1 × 5 ml Biotrisse CHA Serum (Post-filler serum) |
Biotrisse Classic Forma 20
Description
A classic preparation with cross-linked hyaluronic acid for restoration of soft tissue volume and correction of fine to medium-depth wrinkles and folds. Reticulated hyaluronic acid-based gel for intradermal implantation.
Contains: 1 disposable sterile syringe containing 1 ml of reticulated Hyaluronic Acid-based gel (20 mg / ml), 2 sterile disposable needles 27G 1/2″ (CE 0123).
Important: the dermal injection treatment must be performed by an authorized practitioner in accordance with country regulations.
Technical features
| Concentration | 20 mg / ml |
| Reticulation level | medio |
| Volumization level | 3 |
| Correction areas | Perioral wrinkles Nasolacrimal furrows Glabellar wrinkles Neck Corners of the mouth Lip contours Frontal wrinkles Genital area |
| Indications | Correction of mid-level wrinkles Volume modeling of the lips Correction of crease marks Correction of scars |
| Injection depth | Hypodermis Mid-level / deep dermis |
| Injection methods | Linear Retrograde Layer-by-layer Radial Bolus |
| Effective for | 6–9 months |
| Session schedule | A repeat procedure for contour plasticity is recommended in 6 months. There is a cumulative voluminous and prolonged effect with repeat sessions |
| Package | 1 × 1 ml in sterile blister |
| Needle | 2 × 27G 1/2 |
| Post-procedure set for correction zones | 1 × 5 ml Biotrisse CHA Cream (Post-filler cream) 1 × 5 ml Biotrisse CHA Serum (Post-filler serum) |
Biotrisse Classic Volume 25
Description
A Classic preparation with cross-linked hyaluronic acid for natural volume augmentation and correction of medium-to-deep wrinkles and folds. Reticulated hyaluronic acid-based gel for intradermal implantation.
Contains: 1 disposable sterile syringe containing 1 ml of reticulated Hyaluronic Acid-based gel (25 mg / ml), 2 sterile disposable needles 27G 1/2″ (CE 0123).
Important: the dermal injection treatment must be performed by an authorized practitioner in accordance with country regulations.
Technical features
| Concentration | 25 mg / ml |
| Reticulation level | high |
| Volumization level | 3+ |
| Correction areas | Nasolacrimal furrows Glabellar wrinkles Corners of the mouth Forehead wrinkles Genital area |
| Indications | Correction of deep and mid-level wrinkles Volumizing Contour correction Volume modeling of the lips Deep creases (breakdown of the structural contours of the skin) |
| Injection depth | Mid-level / deep dermis Hypodermis Periosteum |
| Injection methods | Linear Retrograde volume Layer-by-layer Radial Bolus injection at the periosteum level |
| Effective for | 8–10 months |
| Session schedule | A repeat procedure for contour plasticity is recommended in 6–9 months. There is a cumulative volume maintained and prolonged effect with repeat sessions |
| Package | 1 × 1 ml in sterile blister |
| Needle | 2 × 27G 1/2 |
| Post-procedure set for correction zones | 1 × 5 ml Biotrisse CHA Cream (Post-filler cream) 1 × 5 ml Biotrisse CHA Serum (Post-filler serum) |
Biotrisse Evo Soft 20
Description
A specialised preparation with cross-linked hyaluronic acid for detailed correction of static and dynamic wrinkles, gentle correction of lost volume. Reticulated hyaluronic acid-based gel for intradermal implantation.
Contains: 1 disposable sterile syringe containing 1 ml of reticulated Hyaluronic Acid-based gel (20 mg/ml ) and 2 sterile disposable needles 30G 1/2″ (CE 0123 ).
Important: the dermal injection treatment must be performed by an authorized practitioner in accordance with country regulations.
Technical features
| Concentration | 20 mg / ml |
| Reticulation level | ○○○ medium |
| Volumization level | 3+ |
| Correction areas | Perioral wrinkles Periorbital wrinkles Décolletage Neck Genital area |
| Indications | Corrects surface wrinkles and small expression lines Natural lip volume |
| Injection depth | Upper level as needed Mid-level dermis |
| Injection methods | Retrograde Linear Bolus Radial |
| Effective for | 8 months |
| Session schedule | A repeat procedure for contour plasticity is recommended in 6 months |
| Package | 1 × 1 ml in sterile blist |
| Needle | 2 × 30G 1/2 |
| Post-procedure set for correction zones | 1 × 5 ml Biotrisse CHA Cream (Post-filler cream) 1 × 5 ml Biotrisse CHA Serum (Post-filler serum) |
Biotrisse Evo Medium 25
Description
A specific preparation with cross-linked hyaluronic acid for volumetric contouring of face and body. Reticulated hyaluronic acid-based gel for intradermal implantation.
Contains: 1 disposable sterile syringe containing 1 ml of reticulated Hyaluronic Acid-based gel (25 mg/ml ) and 2 sterile disposable needles 27G 1/2″ (CE 0123).
Important: the dermal injection treatment must be performed by an authorized practitioner in accordance with country regulations.
Technical features
| Concentration | 25 mg / ml |
| Reticulation level | ○○○○ high |
| Volumization level | 4 |
| Correction areas | Nasolacrimal furrows Perioral wrinkles Glabellar wrinkles Corners of the mouth Lip contours Frontal wrinkles Genital area |
| Indications | Correction of mid-level and deep wrinkles Volume modeling of the lips Correction of scars Correction of deep crease marks |
| Injection depth | Mid-level/deep dermis Hypodermis |
| Injection methods | Linear Retrograde Bolus puncture channel Radial Bolus (at the periosteum and hypodermis levels) |
| Effective for | 10–12 months |
| Session schedule | A repeat procedure for contour plasticity is recommended in 10 months |
| Package | 1 × 1 ml in sterile bliste |
| Needle | 2 × 27G 1/2 |
| Post-procedure set for correction zones | 1 × 5 ml Biotrisse CHA Cream (Post-filler cream) 1 × 5 ml Biotrisse CHA Serum (Post-filler serum) |
Biotrisse Evo Deep 30
Description
Biotrisse polynucleotide-based injectable treatment contains high-concentration and high-viscosity PDRN for bio-repairing, bio-revitalizing, and rejuvenating of skin. An innovative and effective way to restore skin firmness and elasticity and ensure healthy skin protected against free radicals.
Technical features
| Concentration | 30 mg / ml |
| Reticulation level | very high |
| Volumization level | 4+ |
| Correction areas | Middle third of the face Cheeks Chin Nasolacrimal furrows Nose |
| Indications | Correction of deep wrinkles Volume modeling of facial surfaces Formation of facial contours Correction of scars |
| Injection depth | Mid-level / deep dermis Hypodermis Periosteum |
| Injection methods | Bolus injection at the periosteum level Linear retrograde |
| Effective for | 12–16 months |
| Session schedule | A repeat procedure for contour plasticity is recommended in 10–12 months |
| Package | 1 × 1 ml in sterile blister |
| Needle | 2 × 27G 1/2 |
| Post-procedure set for correction zones | 1 × 5 ml Biotrisse CHA Cream (Post-filler cream) 1 × 5 ml Biotrisse CHA Serum (Post-filler serum) |
Biotrisse Polynucleo 2.5
Description
Polynucleotide-based booster for mature skin with clear signs of ageing; intensive treatment of involutional skin changes.
Contains: 1 disposable sterile syringe containing 1 ml of polymerized polynucleotide-based gel for intradermal implantation (25 mg/ml ), 2 disposable sterile needles 30G 1/2″ ( CE 0123 ).
Important: the dermal injection treatment must be performed by an authorized practitioner in accordance with country regulations.
Technical features
| Ingredients | polymerized polynucleotides (PDRNs): 25 mg / ml (350–500 kDa) Sterile normal saline solution |
| Use and recommendations | For problem skin that has been damaged by an aggressive environment For prevention of age-related skin changes For activating healing in damaged skin For correction of small wrinkles For intensive hydration As a general fortifying procedure for preparing/regenerating skin tissue prior to/after any invasive or aggressive actions on the skin (laser procedures, injections, peeling) For decreasing the rate of biodegradation of cross-linked hyaluronic acid fillers |
| Correction areas | Face Periorbital area Cheeks and cheekbones Neck Décolletage Back of the hands Upper arms Thighs Abdominal skin The skin of the buttocks |
| Indications | Surface wrinkles Mid-size scars Photo-damaged skin Skin with low tonicity and elasticity loss Failure of the skin’s barrier function Skin with lowered immunity |
| Applications | As a light filler/bio-repairer and biorevitalizer |
| Injection methods | Micro-papule Retrograde-linear at the deep dermis level |
| Package | 1 × 1 ml (polynucleotide viscous solution in a single-use syringe in a sterile medical blister) 2 sterile single-use 30G ½” needles |
Biotrisse PolyRegen 2.5
Description
Rejuvenating complex with active ingredients that have bio-revitalizing and anti-aging effect, and help stimulate the activity of fibroblasts thus can promote tissue regeneration and skin rejuvenation.
Technical features
| Ingredients | Polymerized polynucleotides (PDRNs): 25 mg / ml (350–500 kDa) Sterile normal saline solution |
| Use and recommendations | For problem skin that has been damaged by an aggressive environment For prevention of age-related skin changes For activating healing in damaged skin For correction of small wrinkles For intensive hydration As a general fortifying procedure for preparing/regenerating skin tissue prior to/after any invasive or aggressive actions on the skin (laser procedures, injections, peeling) For decreasing the rate of biodegradation of cross-linked hyaluronic acid fillers |
| Correction areas | Face Periorbital area Cheeks and cheekbones Neck Décolletage Back of the hands Upper arms Thighs Abdominal skin The skin of the buttocks |
| Indications | Surface wrinkles Mid-size scars Photo-damaged skin Skin with low tonicity and elasticity loss Failure of the skin’s barrier function Skin with lowered immunity |
| Package | 1 × 1 ml (polynucleotide viscous solution in a single-use syringe, in a sterile blister) For topical use. For professional use only |
